Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes

Clinical Cancer Research

Volumn 16, Issue 5, 2010, Pages 1642-1651

  Ofran, Yishai ^a,c   Kim, Haesook T ^a   Brusic, Vladimir ^a   Blake, Loren ^a   Mandrell, Michael ^a   Wu, Catherine J ^a,c   Sarantopoulos, Stefanie ^a   Bellucci, Roberto ^a   Keskin, Derin B ^a   Soiffer, Robert J ^a   Antin, Joseph H ^a   Ritz, Jerome ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

ADULT; ALGORITHM; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; CANCER RESEARCH; CELLULAR IMMUNITY; CLINICAL EVALUATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; GENE EXPRESSION; GENETIC CODE; GENETIC VARIABILITY; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HISTOCOMPATIBILITY; HLA TYPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOGENICITY; INFORMED CONSENT; MALE; MATHEMATICAL MODEL; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TREATMENT RESPONSE; Y CHROMOSOME;

ADULT; ALGORITHMS; CHROMOSOMES, HUMAN, Y; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA-A ANTIGENS; HUMANS; MALE; MIDDLE AGED; MINOR HISTOCOMPATIBILITY ANTIGENS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 77649177671     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-2701     Document Type: Article

References (42)

1. Bleakley M, Riddell SR. Molecules and mechanisms of the graft versus leukemia effect. Nat Rev Cancer 2004;4:371-80.
2. Shlomchik WD. Graft versus host disease. Nat Rev Immunol 2007;7:340-52.
3. Mullally A, Ritz J. Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 2007;109:1355-62.
4. Goulmy E. Minor histocompatibility antigens: from transplantation problems to therapy of cancer. Hum Immunol 2006;67:433-8.
5. Spaapen RM, Lokhorst HM, Van den Oudenalder K, et al. Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genomewide analysis. J Exp Med 2008;205:2863-72.
6. Norde WJ, Overes IM, Maas F, et al. Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells. Blood 2009;113:2312-23.
7. den Haan JM, Sherman NE, Blokland E, et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995;268:1476-80.
8. Wallny HJ, Rammensee HG. Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature 1990;343:275-8.
9. de Rijke B, van Horssen-Zoetbrood A, Veenbergen S, et al. Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigens. J Immunol Methods 2008;329:125-37.
10. van de Corput L, Chaux P, Van der Meijden ED, et al. A novel approach to identify antigens recognized by CD4 T cells using complemen topsonized bacteria expressing a cDNA library. Leukemia 2005;19:279-85.
11. Akatsuka Y, Nishida T, Kondo E, et al. Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens. J Exp Med 2003;197:1489-500.
12. Kawase T, Akatsuka Y, Torikai H, et al. Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen. Blood 2007;110:1055-63.
13. Brickner AG, Warren EH, Caldwell JA, et al. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med 2001;193:195-206.
14. Kamei M, Nannya Y, Torikai H, et al. HapMap scanning of novel human minor histocompatibility antigens. Blood 2009;113:5041-8.
15. Spierings E, Brickner AG, Caldwell JA, et al. The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood 2003;102:621-9.
16. Akatsuka Y, Morishima Y, Kuzushima K, Kodera Y, Takahashi T. Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions. Cancer Sci 2007;98:1139-46.
17. The International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449:851-61.
18. Wang W, Meadows LR, den Haan JM, et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 1995;269:1588-90.
19. Meadows L, Wang W, den Haan JM, et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 1997;6:273-81.
20. Pierce RA, Field ED, den Haan JM, et al. Cutting edge: the HLAA* 0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J Immunol 1999;163:6360-4.
21. Vogt MH, de Paus RA, Voogt PJ, Willemze R, Falkenburg JH. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood 2000;95:1100-5.
22. Vogt MH, Goulmy E, Kloosterboer FM, et al. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood 2000;96:3126-32.
23. Warren EH, Gavin MA, Simpson E, et al. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J Immunol 2000;164:2807-14.
24. Torikai H, Akatsuka Y, Miyazaki M, et al. A novel HLA-A*3303- restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene. J Immunol 2004;173:7046-54.
25. Rosinski KV, Fujii N, Mito JK, et al. DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells. Blood 2008;111:4817-26.
26. Zorn E, Miklos DB, Floyd BH, et al. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J Exp Med 2004;199:1133-42.
27. Vogt MH, van den Muijsenberg JW, Goulmy E, et al. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood 2002;99:3027-32.
28. + T-helper cells in H-Y-mismatched transplantation. Lancet 2003;362:610-15.
29. Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 2004;103:347-52.
30. Stern M, Passweg JR, Locasciulli A, et al. Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. Transplantation 2006;82:218-26.
31. Nicholls S, Piper KP, Mohammed F, et al. Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition. Proc Natl Acad Sci U S A 2009;106:3889-94.
32. Arg null allele. J Immunol 2009;182:4809-16.
33. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 2001;98:31-6.
34. Hansen JA. Genomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality. Biol Blood Marrow Transplant 2008;15:e1-7.
35. + T cells are found in a high proportion of women following pregnancy with a male fetus. Biol Reprod 2007;76:96-101.
36. Kollgaard T, Hadrup SR, Petersen SL. Natural T-cell responses against minor histocompatibility antigen (mHag) HY following HLA-matched hematopoietic cell transplantation: what are the requirements for a 'good' mHag? Leukemia 2008;22:1948-51.
37. James E, Chai JG, Dewchand H, Macchiarulo E, Dazzi F, Simpson E. Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood 2003;102:388-93.
38. Verdijk RM, Kloosterman A, Pool J, et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 2004;103:1961-4.
39. van Halteren AG, Jankowska-Gan E, Joosten A, Blokland E, Pool J, et al. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood 2009;114:2263-72.
40. Warren EH, Vigneron NJ, Gavin MA, et al. An antigen produced by splicing of noncontiguous peptides in the reverse order. Science 2006;313:1444-7.
41. Miklos DB, Kim HT, Miller KH, et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 2005;105:2973-8.
42. Miklos DB, Kim HT, Zorn E, et al. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood 2004;103:353-9.